Literature DB >> 16954803

Correlation between cyclical epithelial barrier dysfunction and bacterial translocation in the relapses of intestinal inflammation.

Monica Porras1, Maria Teresa Martín, Ping-Chang Yang, Jennifer Jury, Mary H Perdue, Patri Vergara.   

Abstract

BACKGROUND: Although several factors have been implicated in the pathogenesis of inflammatory bowel disease (IBD), the mechanisms underlying the recurrent relapses have not yet been clarified. We hypothesized that epithelial barrier dysfunction, associated with intestinal motor disturbances, could play a key role in exacerbation of inflammatory illness due to an increased uptake of luminal antigen and bacterial translocation.
METHODS: Indomethacin administration to rats induced a long-lasting oscillation of active and quiescent phases of inflammation associated with phases of hypo and hypermotility. Rats selected at either active or quiescent phase and from 2 to 60 days after indomethacin treatment were used. Short-circuit current; conductance and HRP flux were evaluated in small intestinal segments mounted in Ussing Chambers. Enterocyte endosomes containing HRP and ultrastructural damage were assessed by electron microscopy. Bacterial translocation was determined by cultures from mesenteric lymph nodes.
RESULTS: Rats with induced enteritis in both phases demonstrated a long-lasting increase of epithelial paracellular permeability. In contrast, transcellular permeability was only disturbed during the active phases, coinciding with bacterial translocation and the increase in inflammatory parameters. Furthermore, although mithochondrial damage was observed throughout the inflammatory state, alterations were worse during the active phase.
CONCLUSIONS: The sustained enhancement of paracellular permeability could facilitate the constant passage of luminal antigens through the mucosa, and hence, be the basis for chronicity. By contrast, transcellular permeability only increases during the active phases, when hypomotility and bacterial translocation are also present, suggesting this factor may play a critical role in the course of acute relapses in IBD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954803     DOI: 10.1097/01.mib.0000231571.88806.62

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  26 in total

Review 1.  Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-16       Impact factor: 4.052

2.  Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism.

Authors:  Emma Slack; Siegfried Hapfelmeier; Bärbel Stecher; Yuliya Velykoredko; Maaike Stoel; Melissa A E Lawson; Markus B Geuking; Bruce Beutler; Thomas F Tedder; Wolf-Dietrich Hardt; Premysl Bercik; Elena F Verdu; Kathy D McCoy; Andrew J Macpherson
Journal:  Science       Date:  2009-07-31       Impact factor: 47.728

3.  Enterobacter sakazakii enhances epithelial cell injury by inducing apoptosis in a rat model of necrotizing enterocolitis.

Authors:  Catherine J Hunter; Vijay K Singamsetty; Nikunj K Chokshi; Patricia Boyle; Victoria Camerini; Anatoly V Grishin; Jeffrey S Upperman; Henri R Ford; Nemani V Prasadarao
Journal:  J Infect Dis       Date:  2008-08-15       Impact factor: 5.226

4.  Stress-induced visceral analgesia assessed non-invasively in rats is enhanced by prebiotic diet.

Authors:  Muriel Larauche; Agata Mulak; Pu-Qing Yuan; Osamu Kanauchi; Yvette Taché
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

5.  Matriptase protects against experimental colitis and promotes intestinal barrier recovery.

Authors:  Sarah Netzel-Arnett; Marguerite S Buzza; Terez Shea-Donohue; Antoine Désilets; Richard Leduc; Alessio Fasano; Thomas H Bugge; Toni M Antalis
Journal:  Inflamm Bowel Dis       Date:  2011-11-13       Impact factor: 5.325

6.  IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens.

Authors:  Sara M Dann; Martina E Spehlmann; Dustin C Hammond; Mitsutoshi Iimura; Koji Hase; Lillian J Choi; Elaine Hanson; Lars Eckmann
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

7.  MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.

Authors:  QiQi Zhou; Wiley W Souba; Carlo M Croce; G Nicholas Verne
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

8.  Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion.

Authors:  M Camilleri; A Nadeau; J Lamsam; S Linker Nord; M Ryks; D Burton; S Sweetser; A R Zinsmeister; R Singh
Journal:  Neurogastroenterol Motil       Date:  2009-07-13       Impact factor: 3.598

9.  Sacral nerve stimulation enhances early intestinal mucosal repair following mucosal injury in a pig model.

Authors:  Jérémy Brégeon; Emmanuel Coron; Anna Christina Cordeiro Da Silva; Julie Jaulin; Philippe Aubert; Julien Chevalier; Nathalie Vergnolle; Guillaume Meurette; Michel Neunlist
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

10.  Host responses to intestinal microbial antigens in gluten-sensitive mice.

Authors:  Jane M Natividad; Xianxi Huang; Emma Slack; Jennifer Jury; Yolanda Sanz; Chella David; Emmanuel Denou; Pinchang Yang; Joseph Murray; Kathy D McCoy; Elena F Verdú
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.